Articles

32 articles
Tag: biotech ✕
Four-Month FDA Delay Forces Biotech Startup Kezar Life Sciences to Shut Down Business
2026-04-07T14:45:04.797Z · Src: 2026-04-07T00:00:00.000Z
fdabiotechstartup
The Precision Fermentation Disruption: How Lab-Grown Proteins Are Reshaping the Trillion Food Industry Science
2026-04-04T20:54:29.892Z · Src: 2026-04-04T00:00:00.000Z
precision fermentatifood techperfect day
The Synthetic Biology Revolution: How AI-Designed Organisms Are Creating a New Industry Science
2026-04-04T18:24:45.800Z · Src: 2026-04-04T00:00:00.000Z
synthetic biologyaiprotein design
The Biotech AI Convergence: How Foundation Models Are Accelerating Drug Discovery and Genomic Medicine Science
2026-04-04T17:55:59.286Z · Src: 2026-04-04T00:00:00.000Z
biotechaidrug discovery
Biotech IPOs Raised .7 Billion in Q1 2026, Most Since 2021 Peak Business
2026-04-04T14:12:57.035Z · Src: 2026-04-04T00:00:00.000Z
biotechipoventure capital
Ambrosia Biosciences Raises Million Series B for Oral GLP-1 Obesity Pill Business
2026-04-04T13:46:25.530Z · Src: 2026-04-04T00:00:00.000Z
ambrosiaglp 1obesity
Biogen Acquires Apellis for .6 Billion, Building Immunology Empire Business
2026-04-04T13:46:07.311Z · Src: 2026-04-04T00:00:00.000Z
biogenapellisbiotech
Eli Lilly Buys Centessa for .3 Billion in Push to Dominate Sleep Disorder Market Business
2026-04-04T13:45:49.970Z · Src: 2026-04-04T00:00:00.000Z
eli lillycentessabiotech
Biotech IPOs Raised .7 Billion in Q1 2026 — Most Since 2021 Bubble Peak Business
2026-04-04T13:45:34.632Z · Src: 2026-04-04T00:00:00.000Z
biotechipoventure capital
Machine Learning Discovers Hundreds of Thousands of Unknown Antiviral Proteins in Bacteria — A 'Treasure Trove' for Biotech Science
2026-04-04T07:29:01.469Z · Src: 2026-04-04T00:00:00.000Z
crisprmachine learningbacteria
Ambrosia Biosciences Raises $100 Million to Challenge Oral Wegovy in the Expanding GLP-1 Pill Market Business
2026-04-04T04:50:46.136Z · Src: 2026-04-04T00:00:00.000Z
glp 1obesityambrosia
Biotech IPOs Raised Record $1.7 Billion in Q1 2026 But Number of Offerings Remains Stubbornly Low Business
2026-04-04T04:50:43.460Z · Src: 2026-04-04T00:00:00.000Z
biotechipoventure capital
Small Biotech Drugmakers Negotiate Tariff Deals with White House as Trade War Intensifies Business
2026-04-04T02:30:54.121Z · Src: 2026-04-04T00:00:00.000Z
biotechtariffswhitehouse
Immunovant Eye Drug Flunks Phase 3 as Biotech Clinical Trial Results Disappoint Investors Business
2026-04-04T01:52:31.276Z · Src: 2026-04-04T00:00:00.000Z
immunovantbeamtherapeuticsalto
Biotech IPOs Grew Larger in Q1 2026 With Median Raise of $287.5 Million Business
2026-04-04T01:52:03.198Z · Src: 2026-04-04T00:00:00.000Z
biotechipoq12026
Ambrosia Raises $100 Million Series B for Oral GLP-1 Obesity Pill, Entering Crowded Race Business
2026-04-04T00:42:13.170Z · Src: 2026-04-04T00:00:00.000Z
ambrosiaglp1obesity
Obesity Drugmaker Kailera Plans IPO After Raising $1B to Challenge Wegovy and Zepbound Business
2026-04-03T14:41:05.267Z · Src: 2026-04-03T00:00:00.000Z
kaileraipoobesity
Merck Strikes $838M Antibody Discovery Deal with Infinimmune as Pharma Ramps Up AI-Driven Drug Research Science
2026-04-03T14:41:00.156Z · Src: 2026-04-03T00:00:00.000Z
merckinfinimmuneantibodies
Blackstone Closes Record $6.3B Life Sciences Fund, Largest Private Equity Vehicle in Sector History Business
2026-04-03T14:40:51.206Z · Src: 2026-04-03T00:00:00.000Z
blackstonelifesciencesprivateequity
How mRNA Technology Beyond COVID Is Transforming Medicine Science
2026-04-01T12:56:00.831Z · Src: 2026-04-01T00:00:00.000Z
mrnamodernabiontech